-
Innovation Ranking
NewInnovation Ranking – SGS SA
SGS SA (SGS) provides inspection, verification, testing, certification, and quality assurance services. The company also provides risk management, consultancy, sustainability solutions, and training services. SGS inspects, samples, analyses, and monitors raw materials, components, and products for compliance with industrial standards and local regulatory requirements, including tax and duty. The company serves various industries including chemical, oil and gas, agriculture and food, construction, energy, life sciences, arts and culture, mining, public sector, logistics, industrial manufacturing, consumer goods and retail, environment, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Primary Systemic Amyloidosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Primary Systemic Amyloidosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SG-2501 in Primary Systemic Amyloidosis Drug Details: SG-2501 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SG-2501 in Relapsed Multiple Myeloma Drug Details: SG-2501 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SG-2501 in Refractory Multiple Myeloma Drug Details: SG-2501 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SG-2501 in Chronic Lymphocytic Leukemia (CLL) Drug Details: SG-2501 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SG-2501 in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drug Details: SG-2501 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SG-2501 in Diffuse Large B-Cell Lymphoma Drug Details: SG-2501 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SG-2501 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drug Details:...
-
Product Insights
SG 4720 Mbada Mine
The SG 4720 Mbada Mine is a diamond mine in Zimbabwe. It is currently in operation. Empower your strategies with our SG 4720 Mbada Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Product Insights
SG Peyrissan Solar PV Park
SG Peyrissan Solar PV Park is a solar PV project located in Nouvelle-Aquitaine, France. The project is owned and developed by ENGIE Green France SAS. The project came online in 2016. Empower your strategies with our SG Peyrissan Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...